GSK and Theravance begin late-stage test for COPD treatment
GlaxoSmithKline has begun Phase III testing on a combined treatment for chronic obstructive pulmonary disease (COPD) with its US project partner Theravance. The global study is the first to evaluate the efficacy and safety of a triple combination of three drugs in 10,000 patients with COPD, all in
Read more